Identification of CD166 as a Surface Marker for Enriching Prostate Stem/Progenitor and Cancer Initiating Cells

New therapies for late stage and castration resistant prostate cancer (CRPC) depend on defining unique properties and pathways of cell sub-populations capable of sustaining the net growth of the cancer. One of the best enrichment schemes for isolating the putative stem/progenitor cell from the murin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiao, Jing, Hindoyan, Antreas, Wang, Shunyou, Tran, Linh M., Goldstein, Andrew S., Lawson, Devon, Chen, Donghui, Li, Yunfeng, Guo, Changyong, Zhang, Baohui, Fazli, Ladan, Gleave, Martin, Witte, Owen N., Garraway, Isla P., Wu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411798/
https://www.ncbi.nlm.nih.gov/pubmed/22880034
http://dx.doi.org/10.1371/journal.pone.0042564

Ejemplares similares

Ejemplares similares